SHE:002821 - Asymchem Laboratories Tianjin Co Ltd

Asymchem Laboratories Tian Jin
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	983M 26.5%	1.16B 18.3%	1.72B 47.6%	2.06B 20.2%	2.98B 44.5%	2.77B -7.0%	2.44B -11.8%	2.25B -8.0%	2.37B 5.5%	1.76B -25.8%	1.44B -18.1%	1.4B -2.9%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	526.13M 18.5%	639.61M 21.6%	972.61M 52.1%	1.13B 16.1%	1.54B 36.6%	1.48B -4.3%	1.25B -15.2%	1.16B -7.3%	1.01B -13.1%	759.06M -24.7%	893.71M 17.7%	790.6M -11.5%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	456.86M 37.1%	523.19M 14.5%	743.24M 42.1%	932.82M 25.5%	1.44B 54.1%	1.3B -9.9%	1.19B -7.9%	1.09B -8.7%	1.36B 25.3%	1B -26.5%	548.42M -45.3%	609.21M 11.1%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	678.42M 8.8%	868.89M 28.1%	1.29B 48.7%	1.45B 11.8%	1.88B 30.0%	1.9B 1.0%	1.86B -1.8%	1.51B -18.7%	1.41B -7.0%	1.24B -12.1%	1.37B 10.7%	1.2B -12.3%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	152.29M -15.1%	229.29M 50.6%	319.75M 39.5%	316.18M -1.1%	336.45M 6.4%	421.75M 25.4%	611.23M 44.9%	353.44M -42.2%	399.72M 13.1%	478.6M 19.7%	476.17M -0.5%	410.65M -13.8%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	304.57M 98.1%	293.9M -3.5%	423.49M 44.1%	616.64M 45.6%	1.1B 78.6%	873.32M -20.7%	581.02M -33.5%	735.21M 26.5%	964.13M 31.1%	523.89M -45.7%	72.25M -86.2%	198.56M 174.8%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	429.33M -	-	-	-	1.74B -	-	-	-	1.68B -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	275M 78.2%	265.52M -3.4%	374.42M 41.0%	499.4M 33.4%	1.24B 148.4%	980.84M -20.9%	580.7M -40.8%	630.35M 8.5%	1.06B 67.5%	523.74M -50.4%	58.7M -88.8%	281.97M 380.3%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.81 77.1%	0.775 -4.2%	1.017 31.1%	1.36 33.8%	3.39 149.3%	2.71 -20.1%	1.56 -42.4%	1.72 10.3%	2.93 70.3%	1.45 -50.5%	0.16 -89.0%	0.76 375%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.81 77.1%	0.775 -4.2%	1.017 31.1%	1.36 33.8%	3.38 148.5%	2.69 -20.4%	1.56 -42.0%	1.72 10.3%	2.93 70.3%	1.45 -50.5%	0.16 -89.0%	0.76 375%